help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohan, S.
Right arrow Articles by Baylink, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohan, S.
Right arrow Articles by Baylink, D. J.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 637-647, Copyright © 1995 by Endocrine Society

ARTICLES

Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation

S Mohan and DJ Baylink
Department of Medicine, Loma Linda University and Pettis Veterans Administration Medical Center, California 92357.

Insulin-like growth factor (IGF)s circulate in plasma as large mol wt proteins bound to specific proteins, termed IGF-binding proteins (IGFBPs). As IGFBPs have been shown to produce artifacts in IGF radioligand assays, various extraction procedures have been proposed to eliminate IGFBPs from biological samples before radioligand assays. Comparison of acid-ethanol and C18 Sep-Pak extraction methods, the two most widely used procedures for separation of IGFs from IGFBPs in human serum samples, with the established gold standard (Sephadex G-75 acid gel filtration) revealed that a significant amount of IGFBP activity survived the acid-ethanol extraction and C18 Sep-Pak separation techniques. We, therefore, have developed a simple novel method comprising a combination of two techniques, involving separation based on size and separation based on centrifugation. In this method, serum samples were acidified and applied to Bio-Spin columns containing BSA- pretreated Bio-Gel Polyacrylamide-10 (P-10). Upon centrifugation, IGFBPs eluted in the void volume. IGFs were then eluted with 1 mol/L acetic acid containing 0.1 mol/L NaCl upon subsequent centrifugation. The efficacy of Bio-Spin P-10 separation for the complete removal of IGFBPs was determined by Western ligand blot analysis and determination of IGFBP-3 levels by RIA in the extracted serum samples. The recovery of exogenously added IGF-I to the serum samples was greater than 90%. Comparison of IGF-I and IGF-II values determined in 12 human serum samples after Bio-Spin P-10 separation with those obtained after separation with the established gold standard method (Sephadex G-75) revealed a correlation greater than 0.9. In contrast to the established gold standard method, which is tedious and time consuming, Bio-Spin P- 10 separation offers the advantage of speed, such that 50 or more samples can be processed in less than 4-6 h. Application of Bio-Gel P- 10 gel filtration to determine the IGF-I and IGF-II levels in 14 normal and 15 age-matched postmenopausal osteoporotic women revealed that 1) both IGF-I and IGF-II levels were reduced by 30% (P < 0.01) and 20% (P < 0.05), respectively, in osteoporotics; and 2) both IGF-I and IGF-II levels correlated with bone mineral density in the pooled data from normal and osteoporotic populations even when age was held constant (P < 0.05).


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. E. Govoni, J. E. Wergedal, R. B. Chadwick, A. K. Srivastava, and S. Mohan
Prepubertal OVX increases IGF-I expression and bone accretion in C57BL/6J mice
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1172 - E1180.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
K. E. Govoni, L. R. Donahue, C. Marden, and S. Mohan
Complex genetic regulation of bone mineral density and insulin-like growth factor-I in C57BL/6J-Chr #A/J/NaJ chromosome substitution strains
Physiol Genomics, October 8, 2008; 35(2): 159 - 164.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. E. Govoni, J. E. Wergedal, L. Florin, P. Angel, D. J. Baylink, and S. Mohan
Conditional Deletion of Insulin-Like Growth Factor-I in Collagen Type 1{alpha}2-Expressing Cells Results in Postnatal Lethality and a Dramatic Reduction in Bone Accretion
Endocrinology, December 1, 2007; 148(12): 5706 - 5715.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
K. E. Govoni, S. K. Lee, Y.-S. Chung, R. R. Behringer, J. E. Wergedal, D. J. Baylink, and S. Mohan
Disruption of insulin-like growth factor-I expression in type II{alpha}I collagen-expressing cells reduces bone length and width in mice
Physiol Genomics, August 20, 2007; 30(3): 354 - 362.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. K. Saxon, A. G. Robling, A. B. Castillo, S. Mohan, and C. H. Turner
The skeletal responsiveness to mechanical loading is enhanced in mice with a null mutation in estrogen receptor-beta
Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E484 - E491.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
J. Svensson, A. Tivesten, K. Sjogren, O. Isaksson, G. Bergstrom, S. Mohan, J. Molne, J. Isgaard, and C. Ohlsson
Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression
J. Endocrinol., June 1, 2007; 193(3): 359 - 366.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
C K Hilleson-Gayne and J A Clapper
Effects of decreased estradiol-17{beta} on the serum and anterior pituitary IGF-I system in pigs
J. Endocrinol., December 1, 2005; 187(3): 369 - 378.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
S Mohan and D J Baylink
Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences
J. Endocrinol., June 1, 2005; 185(3): 415 - 420.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. Fleenor, J. Oden, P. A. Kelly, S. Mohan, S. Alliouachene, M. Pende, S. Wentz, J. Kerr, and M. Freemark
Roles of the Lactogens and Somatogens in Perinatal and Postnatal Metabolism and Growth: Studies of a Novel Mouse Model Combining Lactogen Resistance and Growth Hormone Deficiency
Endocrinology, January 1, 2005; 146(1): 103 - 112.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
C A Sharp, S J Brown, M W J Davie, P Magnusson, and S Mohan
Increased matrix concentrations of IGFBP-5 in cancellous bone in osteoarthritis
Ann Rheum Dis, September 1, 2004; 63(9): 1162 - 1165.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. A. M. Salih, G. Tripathi, C. Holding, T. A. M. Szestak, M. I. Gonzalez, E. J. Carter, L. J. Cobb, J. E. Eisemann, and J. M. Pell
Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice
PNAS, March 23, 2004; 101(12): 4314 - 4319.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Y. Kasukawa, D. J. Baylink, R. Guo, and S. Mohan
Evidence that Sensitivity to Growth Hormone (GH) Is Growth Period and Tissue Type Dependent: Studies in GH-Deficient lit/lit Mice
Endocrinology, September 1, 2003; 144(9): 3950 - 3957.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Mohan, G. Masinde, X. Li, and D. J. Baylink
Mapping Quantitative Trait Loci That Influence Serum Insulin-Like Growth Factor Binding Protein-5 Levels in F2 Mice (MRL/MpJ X SJL/J)
Endocrinology, August 1, 2003; 144(8): 3491 - 3496.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Mohan, C. Richman, R. Guo, Y. Amaar, L. R. Donahue, J. Wergedal, and D. J. Baylink
Insulin-Like Growth Factor Regulates Peak Bone Mineral Density in Mice by Both Growth Hormone-Dependent and -Independent Mechanisms
Endocrinology, March 1, 2003; 144(3): 929 - 936.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Ueland, K. Brixen, L. Mosekilde, L. Mosekilde, A. Flyvbjerg, and J. Bollerslev
Age-Related Changes in Cortical Bone Content of Insulin-Like Growth Factor Binding Protein (IGFBP)-3, IGFBP-5, Osteoprotegerin, and Calcium in Postmenopausal Osteoporosis: A Cross-Sectional Study
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1014 - 1018.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. B. O'Gorman, J. Weiss, A. Hettiaratchi, S. M. Firth, and C. D. Scott
Insulin-Like Growth Factor-II/Mannose 6-Phosphate Receptor Overexpression Reduces Growth of Choriocarcinoma Cells in Vitro and in Vivo
Endocrinology, November 1, 2002; 143(11): 4287 - 4294.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Ueland, J. Bollerslev, A. Flyvbjerg, T. B. Hansen, N. Vahl, and L. Mosekilde
Effects of 12 Months of GH Treatment on Cortical and Trabecular Bone Content of IGFs and OPG in Adults with Acquired GH Deficiency: A Double-Blind, Randomized, Placebo-Controlled Study
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2760 - 2763.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Miyakoshi, Y. Kasukawa, T. A. Linkhart, D. J. Baylink, and S. Mohan
Evidence That Anabolic Effects of PTH on Bone Require IGF-I in Growing Mice
Endocrinology, October 1, 2001; 142(10): 4349 - 4356.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Miyakoshi, X. Qin, Y. Kasukawa, C. Richman, A. K. Srivastava, D. J. Baylink, and S. Mohan
Systemic Administration of Insulin-Like Growth Factor (IGF)-Binding Protein-4 (IGFBP-4) Increases Bone Formation Parameters in Mice by Increasing IGF Bioavailability via an IGFBP-4 Protease-Dependent Mechanism
Endocrinology, June 1, 2001; 142(6): 2641 - 2648.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Miyakoshi, C. Richman, X. Qin, D. J. Baylink, and S. Mohan
Effects of Recombinant Insulin-Like Growth Factor-Binding Protein-4 on Bone Formation Parameters in Mice
Endocrinology, December 1, 1999; 140(12): 5719 - 5728.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
C. Richman, D. J. Baylink, K. Lang, C. Dony, and S. Mohan
Recombinant Human Insulin-Like Growth Factor-Binding Protein-5 Stimulates Bone Formation Parameters in Vitro and in Vivo
Endocrinology, October 1, 1999; 140(10): 4699 - 4705.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Libanati, D. J. Baylink, E. Lois-Wenzel, N. Srinivasan, and S. Mohan
Studies on the Potential Mediators of Skeletal Changes Occurring during Puberty in Girls
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2807 - 2814.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Khosravi, A. Diamandi, J. Mistry, and R. G. Krishna
The High Molecular Weight Insulin-Like Growth Factor-Binding Protein Complex: Epitope Mapping, Immunoassay, and Preliminary Clinical Evaluation
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2826 - 2833.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
P. J. Kaplan, S. Mohan, P. Cohen, B. A. Foster, and N. M. Greenberg
The Insulin-like Growth Factor Axis and Prostate Cancer: Lessons from the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Model
Cancer Res., May 1, 1999; 59(9): 2203 - 2209.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Olivecrona, A. Hilding, C. Ekström, H. Barle, B. Nyberg, C. Möller, P. J. Delhanty, R. C. Baxter, B. Angelin, T. J. Ekström, et al.
Acute and Short-Term Effects of Growth Hormone on Insulin-Like Growth Factors and Their Binding Proteins: Serum Levels and Hepatic Messenger Ribonucleic Acid Responses in Humans
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 553 - 560.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Ueland, J. Bollerslev, T. B. Hansen, E. N. Ebbesen, L. Mosekilde, K. Brixen, A. Flyvbjerg, and O. Djøseland
Increased Cortical Bone Content of Insulin-Like Growth Factors in Acromegalic Patients
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 123 - 127.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
S. Rajaram, D. J. Baylink, and S. Mohan
Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions
Endocr. Rev., December 1, 1997; 18(6): 801 - 831.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
M. T. Overgaard, H. B. Boldt, L. S. Laursen, L. Sottrup-Jensen, C. A. Conover, and C. Oxvig
Pregnancy-associated Plasma Protein-A2 (PAPP-A2), a Novel Insulin-like Growth Factor-binding Protein-5 Proteinase
J. Biol. Chem., June 8, 2001; 276(24): 21849 - 21853.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society